-
Product Insights
NewPancreatic Diseases – Drugs In Development, 2024
Empower your strategies with our Pancreatic Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatic diseases encompass a range of conditions that affect the pancreas, a vital organ located behind the stomach. The pancreas plays a crucial role in digestion and hormone regulation by producing enzymes for digestion and hormones like insulin and glucagon that regulate blood sugar levels. The Pancreatic Diseases drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewAppetite (Eating) Disorders – Drugs In Development, 2024
Empower your strategies with our Appetite (Eating) Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Appetite (eating) disorders are psychological conditions that affect how people think and behave regarding food and their body weight and shape. They can cause serious health problems and even death if not treated. Some of the most common types are anorexia nervosa, bulimia nervosa, binge-eating disorder, and avoidant restrictive food intake disorder. People with these disorders may have symptoms such as...
-
Product Insights
NewHuntington Disease – Drugs In Development, 2024
Empower your strategies with our Huntington Disease – Drugs In Development, 2024 report and make more profitable business decisions. Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child through a mutation in their genes. Early symptoms of HD include uncontrolled movements, clumsiness, and balance problems. Later, HD can take away the ability to walk, talk, and swallow. The Huntington...
-
Product Insights
NewRecessive X Chromosome Disorders – Drugs In Development, 2024
Empower your strategies with our Recessive X Chromosome Disorders – Drugs In Development, 2024 report and make more profitable business decisions. A recessive X chromosome disorder, also known as an X-linked recessive disorder, is a genetic condition caused by a mutation on one of the X chromosomes, one of the two sex chromosomes. Typically, males have one X and one Y chromosome (XY), while females have two X chromosomes (XX). In recessive X-linked disorders, the mutated gene is located on the...
-
Product Insights
NewDuchenne Muscular Dystrophy – Drugs In Development, 2024
Empower your strategies with our Duchenne Muscular Dystrophy – Drugs In Development, 2024 report and make more profitable business decisions. Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscles to gradually weaken over time. Signs and symptoms of DMD include fatigue, learning difficulties, intellectual disability, muscle weakness, and progressive difficulty walking. Risk factors include gender and family history. Treatments include steroid medication, respiratory therapy, and surgery. The Duchenne Muscular Dystrophy drugs in development market research report provide comprehensive information...
-
Product Insights
MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
MRI Systems Pipeline Market Report Overview Magnetic Resonance Imaging (MRI) generates clear and detailed images of internal organs and tissues using radiofrequency and a strong magnetic field. MRI is generally preferred for the diagnosis of brain and other neurological disorders. The 3T, 1.5T and 0.2-1.2T MRI systems have been tracked under this category. The MRI Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...
-
Product Insights
Remote Patient Monitoring Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Remote Patient Monitoring Pipeline Market Report Overview Remote patient monitoring devices are used to retrieve and transmit data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The Remote Patient Monitoring pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Product Insights
Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Multiparameter Patient Monitoring Pipeline Market Report Overview Multiparameter patient monitoring includes devices used for continuous monitoring of physiological and vital parameters such as temperature, blood pressure (BP), oxygen saturation in blood (SpO2), respiration rate (RR), and capnography (CO2) in patients continuously. These types of monitors are used in emergency settings, operation theatres (OT), intensive care units (ICU), and physician’s clinics. The multiparameter patient monitoring pipeline market research report provides comprehensive information about the Multiparameter patient monitoring pipeline products with a...
-
Product Insights
NewNet Present Value Model: Wave Life Sciences Ltd’s WVEN-531
Empower your strategies with our Net Present Value Model: Wave Life Sciences Ltd's WVEN-531 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Wave Life Sciences Ltd’s WVEN-531
Empower your strategies with our Net Present Value Model: Wave Life Sciences Ltd's WVEN-531 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.